F
Fangsheng Medical
Provides innovative internet medical care, health service management, and collaborative solutions for emergency rescue, microbial intestinal flora, and sleep improvement
About Fangsheng Medical
Fangsheng Yikang, legally known as Fang Sheng (Beijing) International Bio-Technology Co., Ltd., is a venture capital-backed entity operating within China's expansive healthcare sector. Founded in 2022, the company is situated in Suzhou, Jiangsu, and directs its focus on providing internet-based medical services. Its core mission is to develop and deliver multi-dimensional, full-life-cycle maintenance products and services aimed at improving quality of life.
The company functions as an investment holding group with a strategic emphasis on medical investment and hospital management across mainland China and internationally. Fangsheng Medical's business model leverages capital to introduce advanced medical technologies and management concepts from abroad. It pursues growth through a variety of strategies including mergers and acquisitions, management consulting, and entrusted management for other healthcare facilities. This approach has led to the establishment of what the company refers to as the “Fang Sheng Medical Model,” which integrates capital leverage with advanced management experience and precise service positioning.
Financially, Fangsheng Yikang has demonstrated its ability to attract significant investment. In April 2024, the company successfully closed an Early Stage Series A venture capital round, raising $10 million. The company is currently generating revenue, indicating that its products and services have achieved a degree of market traction. Looking forward, Fangsheng Medical aims to build a substantial network of general and specialty chain hospitals, creating a competitive medical service industry network to address the diverse healthcare needs of the Chinese public. This long-term vision involves establishing a major industrial platform through the strategic distribution of medical chain institutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 18.7/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotechnology, Biotech and Pharma, DT and LS, science-based
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Apr 2024 | $10M | $40M | FULLSTATE GROUP | ↗ |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Fangsheng Medical in the Suzhou Shi ecosystem
The Fangsheng Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- FGFULLSTATE GROUP
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Fangsheng Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Fangsheng Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









